Saber, M., Sarhan, H., Fouad, Y., Elsayed, M., Hassnine, A. (2022). Overview on Hepatitis B vaccination. The Egyptian Journal of Hospital Medicine, 86(1), 696-699. doi: 10.21608/ejhm.2022.215573
Mona Ali Saber; Hatem Abdul-Monsef Sarhan; Yasser Mahrous Fouad; Mahmoud MA Elsayed; Alshymaa Ahmed Hassnine. "Overview on Hepatitis B vaccination". The Egyptian Journal of Hospital Medicine, 86, 1, 2022, 696-699. doi: 10.21608/ejhm.2022.215573
Saber, M., Sarhan, H., Fouad, Y., Elsayed, M., Hassnine, A. (2022). 'Overview on Hepatitis B vaccination', The Egyptian Journal of Hospital Medicine, 86(1), pp. 696-699. doi: 10.21608/ejhm.2022.215573
Saber, M., Sarhan, H., Fouad, Y., Elsayed, M., Hassnine, A. Overview on Hepatitis B vaccination. The Egyptian Journal of Hospital Medicine, 2022; 86(1): 696-699. doi: 10.21608/ejhm.2022.215573
Background: Hepatitis B virus (HBV) infection is increasing globally, posing a serious public health problem. Hepatitis B virus (HBV) infection and mortality are among the leading causes of death worldwide. Concerns for public health are amplified by the fact that about a third of the world's population is afflicted with HBV. HBV infection may result in cirrhosis, hepatocellular cancer, or both (HCC).
Immunization is the most cost-effective strategy available worldwide for controlling and preventing hepatitis B in terms of benefit-cost ratio. Objective: This review article discusses the most critical components of the HBV vaccine and the most efficient strategies for increasing HBV vaccination.